News

GWPH

What You Need to Know Before Investing in Cannabis Stocks

Michael Jacobs | Equities.com |

Many investors are wondering about how they can get into the game.


Lexaria (LXRP): Groundbreaking Technology that Makes Marijuana (and many other things) more Potent

Spotlight Companies | Equities.com |

​When we consume foods the common misconception is that we absorb 100% of the beneficial molecules. This is simply not the case because what is actually absorbed into our body can depend on


​Four Easter Stocks that Have Risen from the Dead

Joel Anderson | Equities.com |

Easter commemorates Jesus rising from the dead, so here are four stocks that have similarly resurrected themselves of late.


​Zynerba CEO Addresses GW Pharma’s Big News at 28th Annual ROTH Conference

Henry Truc | Equities.com |

Both cannabis biotech stocks soared over 100% on the news.


GW Pharma Explodes +120% on Positive Cannabis Testing for Epilepsy

Equities Staff | Equities.com |

Leader in Cannabis commercialization explodes higher after positive test in Epilepsy as the first placebo-controlled evidence to support safety and efficacy of pharmaceutical cannabidiol in children


REPORT: The Cannabis Biotech/Pharma Market Could Surpass $20 Billion by 2020

Viridian Capital Advisors | Equities.com |

The Biotech opportunity in cannabis is one of the most intriguing and significant investment opportunities in the entire cannabis sector. Biotech companies are looking to capitalize on the


How Investors Can Profit Off of Oversold Biotech and Drug Stocks

The Life Sciences Report | Equities.com |

Several controversies have taken the air out of drug and biotech stocks, which performed quite well until midsummer. Among the injured players are generic drug makers, which landed hard after a


Building for the Marijuana Industry of Today and Tomorrow: An Interview with Abattis Bioceuticals

Spotlight Companies | Equities.com |

The marijuana industry is one with great promise…and relative uncertainty. Navigating the ever-changing regulatory environment is often fraught with difficulties, making it difficult to do


Therapies to Target for Life Science Investors

The Life Sciences Report | Equities.com |

Building on another blockbuster year in specialty pharmacy and generics, Rohit Vanjani, a senior analyst at Oppenheimer & Co., has reason to be excited for 2015. Vanjani specializes in


Interview with 420 Investor's Alan Brochstein: Why Have Marijuana Stocks Gone Up in Smoke?

Alan Brochstein | Equities.com |

It wasn’t too long ago that all any investor could talk about was the red-hot marijuana industry and the skyrocketing stocks. At the time, the legalization of marijuana for recreational


World Economic Forum at Davos 2019 - Ben Yablon Executive VP Salt Lending

Matt Bird sits down with Ben Yablon - Executive VP of Salt Lending - at the World Economic Forum in Davos January 2019